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Background: Chronic exposure to high level of inorganic arsenic in drinking water has been associated with Type 2
Diabetes (T2D). Most research has been ecological in nature and has focused on high levels of arsenic exposure
with few studies directly measuring arsenic levels in drinking water as an index of arsenic exposure. The effect of
low to moderate levels of arsenic exposure on diabetes risk is largely unknown thus our study is adding further
knowledge over previous works.
Methods: This cross sectional study was conducted in 1004 consenting women and men from 1682 eligible
participants yielding a participation rate of 60%. These participants are aged >30 years and were living in
Bangladesh and had continuously consumed arsenic-contaminated drinking water for at least 6 months. T2D cases
were diagnosed using glucometer following the new diagnostic criteria (Fasting Blood Glucose > 126 mg/dl) from
the WHO guideline (WHO 2006), or a self-reported physician diagnosis of type 2 diabetes. Association between T2D
and chronic arsenic exposure was estimated by multiple logistic regression with adjustment for age, sex, education,
Body Mass Index (BMI) and family history of T2D.
Results: A total of 1004 individuals participated in the study. The prevalence of T2D was 9% (95% CI 7-11%).
After adjustment for diabetes risk factors, an increased risk of type 2 diabetes was observed for arsenic
exposure over 50 μg/L with those in the highest category having almost double the risk of type 2 diabetes
(OR=1.9 ; 95% CI 1.1-3.5). For most levels of arsenic exposure, the risk estimates are higher with longer
exposure; a dose–response pattern was also observed.
Conclusions: These findings suggest an association between chronic arsenic exposure through drinking water
and T2D. Risks are generally higher with longer duration of arsenic exposure. The risk of T2D is highest
among those who were exposed to the highest concentration of arsenic for more than 10 years.Background
Arsenic is a recognised carcinogen and toxicant [1,2].
It has a wide range of adverse health effects including can-
cer of the skin and internal organs, chronic bronchitis,
hypertension, and skin lesions such as hyper pigmentation,
and hyper keratoses. Chronic arsenic exposure has also
been reported to be a potential risk factor for type 2 dia-
betes [3-6]. T2D is a metabolic disorder characterized by* Correspondence: Milton.Hasnat@newcastle.edu.au
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reproduction in any medium, provided the orhyperglycaemia, insulin resistance in peripheral tissues,
and altered insulin secretory capacity of pancreatic β cells
[7,8]. Type 2 diabetes accounts for 90-95% of all cases of
diabetes and is a major public health problem worldwide
[9]. Established risks factors of T2D include older age,
obesity, physical inactivity, family history, and genetic
polymorphisms [10]. In addition, environmental toxi-
cants, including arsenic, have been suggested to play an
aetiologic role in developing diabetes [5,6,11], although
this association is yet to be established.
Previous studies reported a possible association
between chronic ingestion of arsenic in drinking water
and T2D [5,6,12], although some of these studies ared. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tioned [9,11,13]. Recently, Chen et al., reported no asso-
ciation between arsenic exposure from drinking water
and diabetes mellitus in a study conducted in Araihazar,
an upazila (sub-district) of Narayangonj District, Dhaka,
Bangladesh [14]. Experimental studies that explored the
diabetogenic effects of inorganic arsenic also reported
conflicting results [9,15-17]. Overall, the experimental
and epidemiologic evidence is at present insufficient
and inadequate to establish a causal association between
arsenic exposure and T2D.
At least, 20% of the rural population of Bangladesh has
been exposed to naturally occurring arsenic through
drinking water [18]. From the public health context, it is
therefore important to assess the role of arsenic in drink-
ing water as a factor in the development of T2D in Ban-
gladesh. Our cross sectional-analytical study was
designed to examine the association between chronic
arsenic exposure and T2D.
Methods
Overview
Bangladesh is divided into 64 districts, with each district
divided into sub-districts named upazilas, and each upa-
zila further divided into a number of unions. Each union
consists of a number of villages, each with a number of
tube wells from which the inhabitants draw their water
for daily usage including drinking and cooking.
The study was conducted from January to July 2009.
Ethics approval was obtained from the Bangladesh
Medical Research Council (BMRC) and the Human
Research Ethics Committee (HREC), The University of
Newcastle, Australia.
Study area and population
After careful review of the Bangladesh Arsenic Mitiga-
tion Water Supply Project’s (BAMWSP) national survey
report, arsenic contaminated areas were selected from
the Kandirpar, Gobindogonj, Uttarda and Modaffargonj
union of the Laksam upazila, and the Jolmuttar union of
the Monohargonj upazila of Comilla; the Sundorpur and
Durgapur unions of the Kaliganj upazila of Jhenidah
were chosen as low arsenic contaminated areas. A union
having > 40% of the tube wells contaminated with
arsenic >50 μg/L, of which 25% had arsenic more than
250 μg/L were considered as a high arsenic contami-
nated area for this study. A union with no tube wells
containing arsenic at more than 50 μg/L was considered
as a low arsenic contaminated area. These areas were
chosen purposively to ensure the study population’s
exposure to a wide range of arsenic that enabled us
to study the effect of various levels of arsenic on
T2D. Comilla and Jhenidah are 100 km south-east and
180 km south-west from Dhaka city, the capital ofBangladesh, respectively. One hundred households were
randomly selected from each of the seven unions. Inter-
viewers visited all selected households in each area.
All individuals present during the household visit who
fulfilled eligibility criteria were recruited in the study
after their informed verbal consent was given. Eligibility
criteria were as follows: aged >30 years, history of drink-
ing water from any tube well for a least 6 months con-
tinuously, and resident in the study area for at least the
preceding 6 months. Those aged less than 30 years or
those with a chronic medical condition except T2D were
deemed ineligible.
Data collection procedure
Six trained field workers conducted a door to door sur-
vey to identify potential participants from the randomly
selected households. Since the literacy rate is low in
the selected sampling areas in Bangladesh, the study
information sheet was read directly in front of potential
participants, and the objectives and expectations of
the study were comprehensively explained. Trained field
workers then obtained informed verbal consent from
the participants.
Interviewers collected information on socio-demo
graphics, and drinking water use history by face to face
interview using a structured questionnaire. The ques-
tionnaire was developed by the researchers and pretested
in a neighbouring village similar to the study area. All
participants underwent a full body examination by a
well-trained physician under sunlight to investigate the
presence of arsenical skin lesions i.e., melanosis, leuco-
melanosis and keratosis. Standing height and weight of
each participant were measured with the subjects wear-
ing light clothes and not wearing shoes. Weight was
measured in kilograms using bathroom scales (Precision
500gm) that were calibrated daily and zeroed before each
measurement. Height was measured in centimetres using
a locally made wooden height board with a metal meas-
urement tape attached. All measurements were made
according to standard WHO procedures [19]. Fasting
blood samples were collected from each participant.
Interviewers confirmed the fasting status verbally before
collecting the blood samples. All field workers were kept
blind to the objectives of the study to reduce observer
bias.
Exposure measurement
A single well water measurement was used to
characterize chronic arsenic exposure for each partici-
pant. We measured the arsenic content of each tubewell
water. In case of participants who changed their arsenic
contaminated tubewell following BAMWSP survey,
we collected water samples from the previous tubewell
as a measure for arsenic exposure. This however, only
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information on duration of drinking water from these
selected tube wells. Cumulative arsenic (total arsenic)
exposure was calculated by multiplying the arsenic
content of the tube well with duration of use of the
well. Drinking water samples were collected from the
selected tube wells, transferred and analysed following
standard procedure [20]. Water arsenic analyses were
performed at a Water Quality Testing Laboratory in
Dhaka using flow injection-hydride generation atomic
absorption spectrometry (FIHG-AAS) following the
standard procedure [20]. The process involves argon
gas as carrier and electrical muffle heater in use to
maintain temperature at 850° C. The hydride vapor
generation involves 1% aqueous solution of Sodium
borohydride and 5ml HCl while 15% aqueous solution
of KI is used as reducing agent with one hour holding
time before hydride generation. The quality control
procedure to measure arsenic in this method involves
several measures such as calibration checks, duplicate
measurements and participation in inter laboratory
comparison exercises. Minimum detection level of ar-
senic by this method is 3μg/L.
Other variables
Information on socio-demographic characteristics such
as age, sex, income, education and occupation, marital
status, drinking water history, smoking history, height,
weight, arsenical skin lesions, family history of T2D and
hypertension were collected. BMI was also calculated
using the standard method (weight in kg / height in
meter2) [21].
Outcome measurement
Participants were classified as having T2D according to
the WHO standard diagnostic criteria: Fasting Blood
Glucose > 126 mg/dl or a self-reported physician diag-
nosis of type 2 diabetes [22]. Fasting Blood samples were
collected in the morning and analysed for blood glucose
levels using an EZ Smart-168 Glucometer (Tyson Biore-
search, Taiwan). All T2D cases identified in this study
were referred to the nearest health facilities for treatment
and follow-up.
Statistical analysis
Data were analysed using Stata statistical analysis soft-
ware, version 10 (Stata, TX, USA, 2001). Frequency
tables and summary statistics were obtained to check
missing data, out of range values and to assess distribu-
tions of continuous variables, and logic checks were
undertaken.
Multiple logistic regressions were done to determine
the association between chronic arsenic exposure and
T2D, adjusting for potential confounders. For theseregression analyses, exposure was initially categorised as
<50 μg/L and >50 μg/L, as 50μg/L is the maximum per-
missible limit of arsenic in drinking water for Bangladesh
[23]; secondarily analyses were done using quartiles of
arsenic levels. To assess the impact of duration of
arsenic exposure (up to 10 years and more than
10 years), we categorized the arsenic concentration as
<50 μg/L and >50 μg/L, and >50 μg/L arsenic con-
centration was sub categorized as 51–250 μg/L and
>250 μg/L [24]. Initially univariate analyses such as chi-
square tests and univariate logistic regression were
undertaken to investigate the relationship between T2D
and chronic arsenic exposure. Potential confounders
such as participant’s age, sex, education (High school
and above; primary class 1–5, no formal education),
occupation (agriculture; day labour; housewives, other),
marital status (currently married, widowed, divorced,
never married, other), total number of household mem-
bers, income (household’s total monthly income), roof
type (straw, tin, concrete, other), smoking history (never,
previous, current), body mass index ( <18.5 as malnour-
ished and >18.5 as normal), and presence of arsenical
skin lesions were included in the initial model. Only
those variables found to be associated at P<0.25 level
of significance in the initial model were included in
the final multiple regression model. Additionally,
we included BMI in the final regression model although
it was not statistically significant at P <0.25 level of sig-
nificance in the initial model as BMI is a known con-
founder for T2D. To estimate the likelihood ratio for
model comparison adjusting for the clustering effect of
tube well (household using the same well), we fitted a
random effect logistic regression model using tube well
id as the random effect variable. We used the random
effect models to estimate likelihood ratio to compare be-
tween nested models while adjusting for clusters. After
we came up with the final set of relevant covariates we
refit a multiple logistic regression model where confi-
dence intervals were estimated using the Huber/White
robust ‘sandwich’ estimator of variance, which is based
on the within cluster correlation observed in the data.
Cuzick's nonparametric test for trend was used to test
for trend across ordered groups.
Results
A total of 1682 people were eligible to participate and
1004 actually agreed, yielding a participation rate of 60%.
Information on baseline characteristics by their drink-
ing water arsenic concentration is presented in Table 1.
Participants’ mean age was 44.9 years (±13.2) and more
females (68.4%) participated than males. Of the total,
69.1% participants received no formal education. The
majority of the participants (67.2%) performed home
duties. More than 98% of participants were married or






Water arsenic concentration No of
subjects %, N1st quartile 2nd quartile 3rd quartile 4th quartile
(10–22 μg/L),%, N (23–32 μg/L), %, N (33–261 μg/L),%, N (≥262 μg/L), %, N
Age
30–39 33 28.9 (117) 20.0 (81) 26.4 (107) 24.7 (100) 40.4 (405)
40–49 33 26.2 (69) 23.2 (61) 26.6 (70) 24.0 (63) 26.2 (263)
50–59 32 36.5 (57) 17.3 (27) 22.5 (35) 23.7 (37) 15.5 (156)
≥60 32 29.4 (53) 22.2 (40) 22.8 (41) 25.6 (46) 17.9 (180)
Sex
Male 86 27.4 (87) 18.0 (57) 22.4 (71) 32.2 (102) 31.6 (317)
Female 32 30.4 (209) 22.1 (152) 26.5 (182) 21.0 (144) 68.4 (687)
Education
No formal education 32 29.8 (207) 22.9 (159) 22.9 (159) 24.4 (169) 69.1 (694)
Primary 32.5 31.2 (58) 18.8 (35) 26.3 (49) 23.7 (44) 18.5 (186)
High School 117.5 25.0 (31) 12.1 (15) 36.3 (45) 26.6 (33) 12.4 (124)
Occupation
Agriculture 109 28.0 (37) 13.7 (18) 26.5 (35) 31.8 (42) 13.1 (132)
Day labour 31 33.4 (17) 23.5 (12) 19.6 (10) 23.5 (12) 5.1 (51)
Housewife 32 30.5 (206) 22.7 (153) 26.1 (176) 20.7 (140) 67.2 (675)
Others 97 24.7 (36) 17.8 (26) 21.9 (32) 35.6 (52) 14.6 (146)
Marital Status
Currently married 33 29.3 (253) 20.3 (175) 25.7 (221) 24.7 (213) 85.9 (862)
Widowed/Divorced 31 32.8 (43) 23.7 (31) 21.4 (28) 22.1 (29) 13.0 (131)
Never married 140 0.0 (0) 27.3 (3) 36.4 (4) 36.3 (4) 1.1 (11)
Religion
Muslim 124 22.3 (171) 15.9 (122) 30.4 (233) 31.4 (240) 76.3 (766)
Hindu 83.5 26.5 (36) 18.4 (25) 22.8 (31) 32.3 (44) 14.2 (136)
BMI
<18.5 109 25.1 (96) 16.2 (62) 27.8 (106) 30.9 (118) 38.0 (382)
18.5-25.0 31 33.5 (176) 22.6 (119) 22.0 (116) 21.9 (115) 52.4 (526)
≥25.0 32 25.0 (24) 29.2 (28) 32.3 (31) 13.5 (13) 9.6 (96)
Smoking Status
Never smoked 32 31.5 (247) 22.6 (177) 24.2 (190) 21.7 (170) 82.1 (784)
Ex smoker 67 31.5 (11) 17.1 (6) 17.1 (6) 34.3 (12) 3.7 (35)
Current smoker 83.5 26.5 (36) 18.4 (25) 22.8 (31) 32.3 (44) 14.2 (136)
Diabetes in the family
Yes 122 25.5 (12) 17.0 (8) 29.8 (14) 27.7 (13) 4.7 (47)
No 32 29.7 (284) 21.0 (201) 25.0 (239) 24.3 (233) 95.3 (957)
* Results are expressed as row percent, unless otherwise indicated.
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among the study participants. Average total monthly
income per household was 69.5 US$ (±66). Study partici-
pants were relatively lean with a mean BMI (kg/m2) of
20.3 (±4.5). Overall, 14.2% of the participants were
current smokers, and mean duration of smoking was
22.6 years (±12.9). A total of 1004 drinking water sam-
ples were collected and analysed. All tubewell water con-
tained arsenic above the minimum detection limit(3 microgram). An average of 5.5 (±2.2) persons was
using each drinking water sample, with a range of 1 to
18 persons. Mean arsenic concentration of the tubewells
were 159 μg/L (±198.5) ranging from 10 to 1401 μg/L.
The overall prevalence of T2D among the study partici-
pants was 9% (95% CI 7%-11%), while 4.7% of the parti-
cipants reported a family history of type 2 diabetes. Only
38% of the participants with T2D were already diag-
nosed, with the remaining 62% being diagnosed on
Table 2 Distribution of characteristics of the study





Men (n, %) 41 (12.9) 276 (87.1)
Age (in years, mean ±sd) 47.3 ± 13.3 44.6 ± 13.2
Education (n, %)
No formal education 55 (61.8) 639 (69.8)
Primary 19 (21.3) 167 (18.3)
>Primary 15 (16.9) 109 (11.9)
Occupation (n, %)
Agriculture 19 (21.3) 113 (12.4)
Daily labourer 4 (4.5) 47 (5.1)
Housewife 47 (52.9) 628 (68.6)
Others 19 (21.3) 127 (13.9)
Marital status (n, %)
Currently married 80 (89.9) 782 (85.5)
Widowed 8 (9.0) 119 (13.0)
Divorced 0 (0.0) 4 (0.4)
Never married 1 (1.1) 10 (1.1)
Religion
Islam 77 (86.5) 689 (75.3)
Hindu 12 (13.5) 77 (24.7)
Total monthly household income (US$)*
mean + SD 74 ± 77 69 ± 65.6
Median 51.5 51.5
Roof type* (n, %)
Tin 79 (88.8) 805 (88.0)
Others 10 (11.2) 109 (12.0)
Body Mass Index (BMI); mean + SD 19.8 + 3.4 20.3 + 4.6
Smoking status* (n, %)
Current smokers 17 (20.0) 119 (13.7)
Ex smokers 6 (7.1) 29 (3.3)
Never smoked 62 (72.9) 722 (83.0))
Duration of smoking (years)*; mean + SD
Current smokers 22.5 ± 11.9 22.5 ± 13.2
Ex smokers 18.3 ± 10.8 19.3 ± 10.5
Family history of Type 2
Diabetes (n, %)
Yes 1 (1.1) 46 (5.0)
No 88 (98.9) 869 (95.0)
* Data were missing for the following variables: Total monthly household
income (1 for cases and 9 for non cases), roof type (1 for non cases), smoking
status (4 for cases and 45 for non-cases) and duration of smoking (2 for ex
smokers).
Table 3 Association of arsenic concentration with type 2
diabetes
Type 2 Diabetes
No. of cases OR* 95% CI
Arsenic concentration (μg/L)
≤50† 33 1.0 -
>50 56 2.1 1.3 – 3.2
Lowest quartile: < 22† 19 1.0 -
2nd quartile: 23 - 32 14 1.1 0.5 – 2.3
3rd quartile: 33 – 261 26 1.7 0.5 – 3.2
Highest quartile: ≥262 30 1.9 1.1 – 3.5
P for trend{ <0.01
* Adjusted for participant’s age, sex, education, BMI, and family history of
diabetes.
† Reference category.
{ Cuzick's nonparametric test for trend across ordered groups; all four groups
were used in trend test.
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older and more likely to be current or ex-smokers
(Table 2).
Results regarding the association of arsenic concen-
tration and type 2 diabetes are given in Table 3. An
increased risk of T2D was observed for arsenic exposureover 50 μg/L with those in the highest quartile category
having almost double the risk of type 2 diabetes (OR=1.9 ;
95% CI 1.1-3.5). The odds ratios showed a dose–response
pattern with a significant increasing trend in relation with
increasing exposure category (p <0.001).We also per-
formed sensitivity analysis excluding participants with
lesser duration of exposure (<2years and <5 years) and
compared them with participants who were exposed for
≥10 years and did not find any difference to that of a com-
parison between <10 years and ≥10 years exposure
groups.
Therefore, the cumulative effects of arsenic concentra-
tion and duration of exposure on T2D are presented in
Table 4. The odds ratio estimates show a graded, dose–
response pattern as arsenic increases and time exposed
increases (p < 0.001). The reference group is those who
had concentrations not exceeding 50μg/L for less than
10 years.
Discussion
We assessed the risk of T2D in people consuming ar-
senic contaminated drinking water in Bangladesh. The
findings suggest an association between chronic arsenic
exposure through drinking water and T2D. Risks are
generally higher with longer duration of arsenic expo-
sure. The risk of T2D is highest among those who
were exposed to the highest concentration of arsenic
(>250μg/L) for more than 10 years.
More females than males participated in this study.
This is because data was collected during the morning
when many of the males were out of the home for their
daily work. The overall prevalence of T2D is higher in
this study than that reported previously in rural Bangla-
desh [25]. The prevalence of T2D is also higher in the
low arsenic area of Kaligonj relative to rural areas of
Bangladesh. This may be due to increased risk of T2D
Table 4 Association of arsenic concentration and










< 50† 33} 1 -
<10 >50 – 250 10 2.05 0.8 – 5.36
>250 06 0.68 0.18 – 2.59
≥10 >50 – 250 16 2.11 1.08 – 4.15
>250 24 2.35 1.28 – 4.32
* Adjusted for participant’s age, sex, bmi and family history of diabetes.
† Reference category.
} In <10 years and ≥10 years exposure groups with ≤50 μg/L arsenic
concentration the number of cases are 19 and 14, respectively.
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drinking water [15].
Studies in Taiwan, Bangladesh, and Mexico have all
shown an association between high levels of inorganic
arsenic in drinking water and increased risk of T2D
[5,6,26-28]. These studies are limited by the use of ecolo-
gic measures of arsenic in drinking water rather than in-
dividual measurements of arsenic exposure through
drinking water. Data from the studies in Taiwan and
Bangladesh were pooled earlier in a meta-analysis [9]
that examined extreme arsenic exposure categories
(village drinking water levels or living in a high-vs-low-
arsenic area); the pooled relative risk for diabetes asso-
ciated with high versus low arsenic areas was 2.52
(95% CI: 1.69 – 3.75).
Only a limited number of studies have examined the
association of low or moderate exposure to inorganic ar-
senic with diabetes risk [29,30]. An early ecological study
in Utah, USA found no association between arsenic
levels in drinking water and diabetes mortality after con-
trolling for age and sex [30]. A cross-sectional study in
Wisconsin, USA that examined the association between
arsenic in drinking water and nine self reported chronic
diseases found that compared to those with an arsenic
exposure <2μg/L, those exposed to 2μg/L -10μg/L and
>10μg/L of arsenic in drinking water had an adjusted
odds ratio of 1.35 (95% CI, 0.78-2.33) and 1.02 (95% CI,
0.49-2.15), respectively [29]. Wang et al., in a previous
study found that hair arsenic levels were associated
with elevated plasma glucose levels and with the preva-
lence of the metabolic syndrome in 660 participants
exposed to relatively low arsenic levels in drinking
water in Taiwan [31]. Chen JW et al in another study
from Taiwan reported a two-fold increased risk of T2D
among subjects with total urinary As (U-As) >75 μg/g
creatinine as compared with individuals whose U-As was
<35 μg/g creatinine after adjustment for potential con-
founders [12]. However, Chen Y et al observed no
association between chronic arsenic exposure anddiabetes mellitus in Bangladesh and they reported a
prevalence of diabetes of 2.1%, low BMI (<20kg/m2) in
49% and exposure to <300μg/L of arsenic in 90% of the
participants [14]. On the other hand, our study reports
diabetes in 9%, low BMI (<20kg/m2) in 55% and expos-
ure to <300μg/L of arsenic in 77% of the participants.
The low prevalence of diabetes among arsenic exposed
people in the Chen Y et al study might be due to the use
of glycated hemoglobin (HbA1C) and glucosuria to iden-
tify diabetic individuals, rather than fasting blood glucose
and 2-hour blood glucose that were used to identify dia-
betics in another study [28]. Inaccuracies in BMI deter-
mination may have contributed to an underestimation of
association with T2D risk in our study. Despite the parti-
cipants in this study might not be representative to the
general population; however the participants staying at
home were more appropriate for the study, as their ex-
posure to arsenic concentration was determined from
the well water they had been consuming.
The mechanism by which arsenic causes T2D is still
largely undefined.
Animal model experimentation suggests that arsenic
impairs pancreatic β cell function, particularly affecting
insulin synthesis and secretion [32,33]. The molecular
mechanism for this effect may be via adverse effects
on insulin signal transduction and the inhibition of
gene transcription factors [34-36]. A few non-specific
mechanisms such as oxidative stress, inflammation or
apoptosis may also increase the risk of developing dia-
betes [32].
Important strengths of this study include the use of a
large population sample, the direct measurement of
arsenic in the subjects’ drinking water, and the adjust-
ment for relevant diabetes risk factors such as age, sex,
education, body mass index (BMI) and family history of
diabetes. While the public health and research implica-
tions of this study are important, some caveats must also
be considered. One limitation of this study is that bio-
markers of arsenic exposure were not measured. Also,
we excluded people with chronic medical conditions
which may be related to arsenic exposure, although this
would tend to bias towards the null and therefore indi-
cates robustness of our results.
Other limitations include the use of a glucometer to
measure fasting glucose as this may give inaccurate
results. Validity of this glucometer has not been tested
earlier. Therefore, there may be misclassification of T2D.
Use of field screening tests to diagnose T2D in relation
to explore association with chronic arsenic exposure has
been a concern. A few previous studies reported an asso-
ciation between T2D and chronic arsenic exposure using
field screening tests such as glucometer for blood, and
glucometric strips for glucosuria [28,37]. Laboratory
facilities are still rare or unavailable in rural Bangladesh
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screening rather than diagnosis for diabetes mellitus
[38]. Nevertheless, interviewers were unaware of the
arsenic concentration levels of the subjects’ usual drink-
ing water. Therefore, this misclassification is likely to be
non-differential, and hence may underestimate the risk.
It would also have been desirable to have directly mea-
sured individual exposure data over time, as the available
water samples reflected only a particular point in time
and not the historical exposure. In the absence of any re-
liable information on past exposure, it was essential to
assume that arsenic concentrations from the tube wells
had been relatively constant over time. The historical
consistency of arsenic concentration is of particular con-
cern with shallow ground water, which might be subject
to greater fluctuation than water from a deeper well.
However, we assume that any fluctuation of arsenic con-
centrations is likely to affect the study participants
equally. Duration of tube well water use was also
obtained from the participants. In the absence of any
good documentation of water use, we had to rely on
the individual’s recall. The study is cross-sectional and
temporality between drinking water arsenic and develop-
ment of T2D cannot be ensured. Prospective epidemio-
logic studies in populations exposed to a wide range of
inorganic arsenic are needed to confirm this association.
Also many other factors need to be considered in any
population studies as diabetes risk increases with age,
obesity and individual’s physical activity [39]. Another
limitation in this study is that we did not adjust for phys-
ical activity. However, we adjusted for obesity in the final
model. Furthermore, obesity and physical activity would
not be an issue in the rural population in Bangladesh as
obesity is much lower [40] and physical activity may be
higher in this context.
Conclusions
Our result adds to the growing body of work indicating
an association between chronic arsenic exposure and
T2D and provides a graded, dose–response relationship.
Such an effect could yield insights into the pathophysi-
ology of diabetes and indicate potential future preventive
and therapeutic targets in diabetic patients and warrants
future larger prospective studies.
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